- Atomoxetine in the treatment of the most common comorbid disorders of…
Number of the records: 1  

Atomoxetine in the treatment of the most common comorbid disorders of attention-deficit / hyperactivity disorder, oppositional defiant disorder and anxiety disorders

  1. ŠNIRCOVÁ, Eva et al. Atomoxetine in the treatment of the most common comorbid disorders of attention-deficit / hyperactivity disorder, oppositional defiant disorder and anxiety disorders. In Acta medica Martiniana. ISSN 1335-8421. Martin : Jesseniova lekárska fakulta Univerzity Komenského v Martine, 2012, 2012, roč. 12, č. 3, s. 28-38.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.